(Q44042009)

29 November 2017

Selective decrease in central nervous system serotonin turnover in children with dopa-nonresponsive dystonia (English)

1 reference

29 November 2017

Birgit Assmann

1

1 reference

29 November 2017

Martin Köhler

2

1 reference

29 November 2017

Georg F Hoffmann

3

1 reference

29 November 2017

Simon Heales

4

1 reference

29 November 2017

Robert Surtees

5

1 reference

29 November 2017

language of work or name

English

0 references

publication date

1 July 2002

1 reference

29 November 2017

1 reference

29 November 2017

52

1 reference

29 November 2017

1

1 reference

29 November 2017

91-94

1 reference

https://scigraph.springernature.com/pub.10.1203/00006450-200207000-00017

29 November 2017

0 references

cites work

Aromatic L-amino acid decarboxylase deficiency: clinical features, diagnosis, and treatment of a new inborn error of neurotransmitter amine synthesis

1 reference

https://api.crossref.org/works/10.1203%2F00006450-200207000-00017

Abnormalities of biogenic amine metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F00006450-200207000-00017

Recessively inherited L-DOPA-responsive parkinsonism in infancy caused by a point mutation (L205P) in the tyrosine hydroxylase gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F00006450-200207000-00017

Interacting neurotransmitter systems. A non-experimental approach to the 5HIAA-HVA correlation in human CSF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F00006450-200207000-00017

Distribution of serotonin-immunoreactivity in the central nervous system of the rat-cell bodies and terminals

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F00006450-200207000-00017

The behavioral effects of NMDA antagonists in serotonin depleted rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F00006450-200207000-00017

Serotonin syndrome complicating migraine pharmacotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F00006450-200207000-00017

Movement Disorders Associated With the Serotonin Selective Reuptake Inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F00006450-200207000-00017

Selective serotonin-reuptake inhibitor-induced movement disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F00006450-200207000-00017

Cerebral metabolites in cerebrospinal fluid as a biochemical approach to the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F00006450-200207000-00017

Tryptophan and 5-hydroxyindoleacetic acid in human cerebrospinal fluid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F00006450-200207000-00017

Sites of origin in the central nervous system of monoamine metabolites measured in human cerebrospinal fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F00006450-200207000-00017

Monoamine metabolites in lumbar CSF: the question of their origin in relation to clinical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F00006450-200207000-00017

Anatomy of the serotonergic system

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F00006450-200207000-00017

Dopa-responsive dystonia: A clinical and molecular genetic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F00006450-200207000-00017

Cerebrospinal Fluid Concentrations of Pterins and Metabolites of Serotonin and Dopamine in a Pediatric Reference Population

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F00006450-200207000-00017

10.1203/00006450-200207000-00017

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

29 November 2017

0 references

1 reference